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32P-Labelled washed rabbit platelets were incubated with 0.6 nM platelet activating factor (PAF-acether), 
giving a full aggregation and release response within 30-60 s. The major phospholipid changes observed 
under these conditions were: (1) An increased labelling of phosphatidic acid (PA) within 10 s and of 
phosphatidylinositol (MPI) at 30 s, reflecting the activation of the MPI cycle via the cytosolic 
phospholipase C; (2) an enhancement of phosphatidylinositol-4-phosphate (DPI) and phosphatidyl- 
inositol-4,5-bisphosphate (TPI) labelling at later incubation times; (3) an early degradation of TPI with 
a counterbalancing formation of DPI. The latter changes suggest a receptor-mediated stimulation of TPI- 
phosphomonoesterase, the role of which in the mechanism of platelet activation is discussed. 
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1. INTRODUCTION 
Phospholipid metabolism in stimulated platelets 
has received much attention. One of the earliest 
changes subsequent to platelet stimulation by 
specific agonists like ADP, thrombin, collagen or 
platelet activating factor (PAF-acether) seems to 
be the activation of a phosphatidylinositol (MPI) 
specific phospholipase C [ 1,2] leading to the pro- 
duction of diglycerides, phosphatidic acid (PA), 
lyso PA and arachidonate [1,3-131. This so-called 
MPI effect was described in numerous tissues 
under specific conditions of stimulation [ 14- 171. 
Other metabolic changes observed in stimulated 
cells involve the polyphosphoinositides (poly(P1)): 
phosphatidylinositol-4-phosphate (DPI) and phos- 
phatidylinositol-4,Sbisphosphate (TPI). An in- 
creased labelling of poly(P1) was revealed in 
platelets stimulated by various agonists 
[3,4,13,18-201. In [21] thrombin promoted a net 
synthesis of platelet DPI and TPI, which occurs as 
a late event and parallels the release of lysosomal 
enzymes. In [22] a specific degradation of TPI was 
observed in the first seconds of platelet activation 
by thrombin: TPI hydrolysis was not dependent on 
calcium mobilization - it was suggested to par- 
ticipate in the release of membrane-bound calcium 
~231. 
Abbreviations: PAF-acether, platelet-activating factor 
or 1-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine; PA, 
phosphatidic acid; MPI, phosphatidylinositol; DPI, 
phosphatidylinositol-4-phosphate; TPI, phosphatidyl- 
inositol-4,5bisphosphate; poly (PI), polyphosphoinosi- 
tides 
* To whom correspondence should be adressed 
This study was undertaken to investigate the 
mechanism of action of PAF-acether, a powerful 
phospholipid mediator able to promote platelet ag- 
gregation and secretion [24-271: besides pro- 
moting an early acitvation of MPI-specific phos- 
pholipase C and a secondary phosphorylation of 
DPI and TPI, PAF-acether also induces an early 
degradation of TPI. 
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2. MATERIALS AND METHODS 
HP32PO:-, di-sodium salt, carrier-free, was ob- 
tained from the Commissariat a I’Energie Atom- 
ique (Saclay). 5-Hydroxy [G-3H]-tryptamine, 
creatinine sulfate (lo-20 Ci/mmol) was from 
NEN (Boston, MA). I-Hexadecyl (rat) glycero- 
phosphorylcholine was purchased from Medmark 
(Heidelberg). Liquid scintillation counting was 
performed using Picofluor 30 (Packard, Palo Alto 
CA) and an LS 3000 spectrophotometer (Kontron, 
Basel). 
2.1. Preparation of washed rabbit blood platelets 
Blood was withdrawn by intracardiac puncture 
of male New Zealand rabbits using 8 mM EDTA 
(pH 7.4) as an anticoagulant. The platelets were 
prepared essentially as in [28]. Labelling was per- 
formed by incubating either platelet-rich plasma 
with [3H]serotonin (100 nCi/ml, 30 min, 20°C) or 
the first washing fluid (5 x lo8 cells/ml) with 
[32P]phosphate (50,&i/ml, 90 min, 20°C). Final 
suspension (5 x lo8 cells/ml) was in Tyrode buffer 
(pH 7.4) containing 1 mM MgCL2, 1 mM CaC12, 
5.5 mM glucose and 3.5 g/l of bovine serum 
albumin. 
2.2. Synthesis of I-hexadecyl-2-acetyl (rat)- 
glycerophosphorylcholine (PAF-acether) 
PAF-acether was obtained according to [25] and 
purified by thin-layer chromatography on silica gel 
[29]. It was stored in ethanol at -20°C until use. 
2.3. Stimulation of the platelets and analytical 
procedures 
PAF-acether was added under a minimal volume 
of ethanol (12J/ml) to prewarmed platelets 
suspension (1 min, 37’C) and incubation was per- 
formed at 37°C under stirring. The same volume 
of ethanol was added to the controls. In alle the ex- 
periments considered, a full aggregation response 
was obtained with 6 x lo-” M PAF-acether. 
Phospholipid analysis: 
Incubation- was blocked by adding 3 vol. 
CHC13/CH30H (l/2, v/v) and EDTA (5 mM, 
final cont.). Lipid extraction was performed as in 
[30]. The procedure was repeated twice and the 
organic layers were washed by 4 vol. 
CH3OH/1.2 N HCl (l/l, v/v) [30]. Phospholipids 
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were separated on oxalate-impregnated silica gel 
plates, using the bidimensional system in [3]. After 
autoradiography, the radioactive spots were 
scraped off and submitted to liquid scintillation 
counting. 
2.4. Determination of the release reaction 
[ 3H]Serotonin was detected for radioactivity in 
supernatants obtained by centrifugation (1500 x g, 
5 min, +4”C) after platelet fixation by formalin 
[ 121. N-Acetyl-P-D-glucosaminidase was measured 
in supernatants obtained after addition of 20 mM 
EDTA according to [31]. 
3. RESULTS 
3.1. Labelling pattern of platelet phospholipids 
Fig. 1 shows an autoradiogram of phospholipids 
extracted from 32P-prelabelled platelets. As 
described in [3-4,6,13,18], only TPI, DPI, MPI 
and PA incorporated significant radioactivity 
(table 1). Another unidentified compound X 
represented 6% of the total radioactivity. Special 
care was taken to identify lyso MPI. A pure stan- 
dard was clearly separated from DPI (fig. 1). 
3.2. Time course of phospholipid changes during 
platelet stimulation by PAF-acether 
Various changes occurred during platelet ag- 
gregation induced by PAF-acether (fig. 2) PA 
radioactivity was increased by 60% after 10 s 
stimulation and levelled off at 30 s, whereas an 
enhanced labelling of MPI appeared secondarily. 
A biphasic response was observed for poly (PI): 
after 10 s, TPI was significantly reduced by 12%, 
whereas DPI displayed a concomitant increase. At 
Table 1 
Radioactive labelling of phospholipid classes in rabbit 
platelets 
Phospholipids Percentages 
TPI 54.9 + 1.5 
DPI 24.3 + 5.5 
PI 9.1 +3 
PA 5.1 + 1 
X 6.1 k 1 
Results are mean + SD of the percentage of the label in 
each phospholipid class vs the whole platelet lipid 
radioactivity 
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Fig. 1. Chromatogram of phospholipids extracted from 
pre-labelled platelets. For extraction conditions see 
section 2. (1) Solvent 1: CHC&/CHsOHN N ammonia 
(9/4/Z, by vol.); (2) Solvent 2: CHCl~/CH3OH/CH3 
COOH/HzO (60/30/12/S, by ~01.); (---> non- 
radioactive iodine-stained lipids; (-) radioactive 
phospholipids detected by autoradiography; (0) origin; 
LPI, lysophosphatidylinositol (pure standard added to 
the lipid extract); SPH, sphingomyeline; PE, phosphati- 
dylethanolamine; LPE, lysophosphatidylethanolamine; 
PS, phosphatidylserine; PC, phosphatidylcholine; PA, 
phosphatidic acid; NL. neutral lipids; FFA, free fatty 
acids; X, unkown; for other abbreviations, see the 
footnote. 
later incubation times, radioactivity of TPI and 
DPI was enhanced over controls, the difference be- 
ing significant for DPI at 60 s. 
In contrast, phospholipid X did not display any 
significant modification during the whole incuba- 
tion time. Also, no radioactive spot was detected at 
the position of lyso MPI. 
Fig. 3 gives for comparison the time course of 3 
platelet responses. At the [PAF-acether] used, 
serotonin release appeared as the earliest event and 
reached 30% of total serotonin at 10 s, when ag- 
gregation and N-acetyl-#7-D-glucosaminidase 
release were still hardly detectable. However, the 
two secretory responses were completed within 
30 s, whereas a full aggregation was obtained at’ 
60 s. 
0 10 30 so 
INCUEWION TIME (S) 
Fig. 2. Effect of PAF-acether on phospholipid meta- 
bolism of pre-labelled rabbit platelets. Results are 
expressed as the ratio of the radioactivity of a given 
phospholipid vs the radioactivity of the same 
phospholipid at time zero. Mean f SD of 6 (10 s) or 
10 (30 s and 60 s) independent experiments: assays 
(e---+); controls (O---O); p < 0.05, according to 
Student’s f-test (*); p < 0.02, (+*); p < 0.01, (or**); 
non-significant (a). 
4. DISCUSSION 
This study reports 3 modifications of inositol- 
phospholipid metabolism occurring in rabbit 
platelets stimulated with PAF-acether. One is the 
activation of the MPI-specific phospholipase C, as 
evidenced by the production of PA, followed by an 
increased labelling of MPI confirming 19,131. As 
discussed in [9], PA produced in the first seconds 
of stimulation might play a central role in the 
mechanism of platelet activation. This would fit 
with the observation that lyso PA are able to pro- 
mote platelet aggregation 132,331. 
As to the increased labelling of DPI and TPI 
happening at later times, similar results were 
reported in [ 131 by measuring the incorporation of 
exogenouso-[32P]phosphate into platelet phospho- 
363 
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Fig. 3. Time course of aggregation and release reaction 
of rabbit platelets upon stimulation with PAF-acether. 
Results are the percentages of [3H]serotonin (o---o) or 
N-acetyl-B-D-glucosaminidase (O---O) in supernatants 
vs the whole platelet content of these markers. 
lipids during PAF-acether challenge. However, 
those changes could be due to an increased mem- 
brane permeability and might not reflect intrinsic 
changes of phospholipid metabolism. Such a 
possibility can be ruled out here, where platelets 
had incorporated the radioactive precursor which 
was only present on the cell interior. These 
modifications are similar to those induced by 
thrombin [l&20,21] and might correspond to an 
increased phosphorylation process. In the later 
case, poly(P1) increase was more closely parallel to 
aggregation and N-acetyl-,8-D-glucosaminidase 
release [21]. It still remains difficult to understand 
the possible relationship between these bio- 
chemical modifications and the process of platelet 
activation. 
The last change we found was a decrease of TPI 
occurring in the first seconds of platelet stimula- 
tion by PAF-acether. Such a modification was 
described in thrombin-treated horse platelets [22]. 
The authors gave evidence that TPI hydrolysis is a 
calcium-independent process and they suggested 
that it migh be due to a phosphomonoesterase [23]. 
Such an hypothesis could be reinforced from our 
present results, since we found a concomitant ac- 
cumulation of DPI. However, one must notice that 
this counterbalancing increase of DPI is not 
stoichiometric to the decrease of TPI since relative 
changes were taken in account, whereas TPI radio- 
activity is twice higher than DPI radioactivity. 
According to [22,23], activation of TPI phos- 
phomonoesterase might be linked to occupancy of 
the thrombin receptor and could be involved in the 
release of membrane-bound calcium, leading to 
further activation of various calcium-dependent 
events. Some evidence is available for the existence 
of a platelet membrane receptor of PAF-acether 
[34,35], which would suggest that both PAF- 
acether and thrombin might act by a common 
mechanism. However, further studies are still 
necessary to better know the platelet enzymes 
responsible for poly(P1) metabolism as well as the 
factors involved in their regulation. 
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